The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me in North Carolina, US

What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft. Dr. Chao is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

Richard Champlin is a Hematologist practicing medicine in Cary, North Carolina. Dr. Champlin is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Uday Popat is a Hematologist practicing medicine in Cary, North Carolina. Dr. Popat is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Elizabeth Shpall is an Oncologist practicing medicine in Cary, North Carolina. Dr. Shpall is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Jonathan Serody is a Hematologist practicing medicine in Chapel Hill, North Carolina. Dr. Serody is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Triple-Negative Breast Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration.

Rohtesh Mehta is a Hematologist practicing medicine in Cary, North Carolina. Dr. Mehta is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Jeffrey Huo is an Oncologist and a Pediatrics provider practicing medicine in Charlotte, North Carolina. Dr. Huo is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His clinical expertise encompasses Graft Versus Host Disease (GvHD), Adult T-Cell Leukemia, Acute Lymphoblastic Leukemia (ALL), Teratoma of the Mediastinum, and Bone Marrow Transplant. Dr. Huo is board certified in American Board Of Pediatrics. Dr. Huo is currently accepting new patients.

I am a doctor and researcher who specializes in bone marrow transplants. Patients usually come to me after their cancer treatment has been unsuccessful or when their disease is high-risk and may require further care. When I first see a patient, it is important for me to hear their story, the history of their condition and their treatment goals. This information is important so we can decide, together, which treatments to pursue and to what degree. For me, it is a privilege to get to know where people come from and to help families through their difficult time. I grew up working in a restaurant, so I was exposed to serving the public at an early age. As I became educated, I decided that I wanted to help others in a different capacity, so I pursued medicine. Outside of work, I like spending time enjoying nature and the beauty of North Carolina with my children and husband. Dr. Sarantopoulos is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Sarantopoulos is board certified in American Board Of Internal Med, Hematology.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft. Dr. Horwitz is board certified in American Board Of Internal Med, Medical Oncology.

Sharon Hymes is an Internal Medicine provider practicing medicine in Cary, North Carolina. Dr. Hymes is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Trichoepithelioma, Multiple Familial Trichoepithelioma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Thyroidectomy.

Katayoun Rezvani is a Hematologist practicing medicine in Cary, North Carolina. Dr. Rezvani is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic B-Cell Leukemia (CBCL), Multiple Myeloma, Leukemia, and Bone Marrow Transplant.

Simrit Parmar is a Hematologist and an Oncologist practicing medicine in Cary, North Carolina. Dr. Parmar is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Edward Copelan is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Copelan is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Copelan is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Hematology. Dr. Copelan is currently accepting new patients.

David Rizzieri is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Rizzieri is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Gwynn Long is a Transplant Surgeon practicing medicine in Durham, North Carolina. He has been practicing medicine for over 43 years. Dr. Long is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Graft. Dr. Long is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

Michael Grunwald is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Grunwald is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Grunwald is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Hematology. Dr. Grunwald is currently accepting new patients.

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.

I’m a pediatric blood and bone marrow transplant specialist. I see patients from all over the world, many of whom have very rare diseases. I take care of patients with leukodystrophies, leukemias and other blood disorders that are resistant to standard treatment, and children with brain injuries like cerebral palsy. It’s rewarding to make a difference when treating challenging diseases. I’ve been fortunate over my career to be able to develop new treatments in the laboratory that I take into the clinic to help patients. In fact, here at Duke I was involved in the first cord-blood transplant anywhere in the world. When meeting with patients, I focus on making their experience more than just the medicine. We have a family support program for things beyond medical needs, which is especially helpful for families that are far from home. Outside of work, I like to knit, bike and spend time with my family. Dr. Kurtzberg is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Metachromatic Leukodystrophy, Graft Versus Host Disease (GvHD), Leukodystrophy, Congenital Athymia, and Bone Marrow Transplant. Dr. Kurtzberg is board certified in American Board Of Pediatrics, General Pediatrics and American Board Of Pediatrics, Pediatric Hematology-Oncology.

Richard Lopez is a Transplant Surgeon practicing medicine in Durham, North Carolina. He has been practicing medicine for over 37 years. Dr. Lopez is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Graft. Dr. Lopez is board certified in American Board Of Internal Med, Medical Oncology.

I focus on treating patients with blood cancers who are considering stem cell or bone marrow transplantation. There have been significant improvements in transplantation over the last 20 years, which has improved outcomes. These improvements include the ability to use lower doses of chemotherapy to reduce toxicity for patients, as well as strategies to reduce the risk of relapse. I am interested in using new therapies and approaches to improve outcomes after stem cell transplantation for blood cancers. It is important to work together with patients to determine their goals for treatment and select the best path forward. I have enjoyed working with patients and their families for many years after their transplant. Dr. Alyea is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Transplant. Dr. Alyea is board certified in American Board Of Internal Med, Medical Oncology.